Viatris (VTRS) Intangibles (2019 - 2026)
Viatris (VTRS) posted quarterly Intangibles of $14.5 billion for Q1 2026, down 13.08% year-over-year from $16.7 billion in Q1 2025, and down 4.1% quarter-over-quarter from $15.1 billion in Q4 2025.
Viatris (VTRS) Intangibles (2019 - 2026) Analysis & Trends
Viatris' Intangibles history runs 8 years deep, the most recent figure standing at $14.5 billion for Q1 2026.
- In Q1 2026, Intangibles fell 13.08% year-over-year to $14.5 billion; the TTM figure through Mar 2026 stood at $14.5 billion (down 13.08% YoY), while the FY2025 annual figure was $15.1 billion, down 11.53% from the prior year.
- Intangibles for Q1 2026 stood at $14.5 billion, down from $15.1 billion in the prior quarter.
- The five-year high for Intangibles was $25.3 billion in Q1 2022, with the low at $14.5 billion in Q1 2026.
- The 5-year median for Intangibles is $19.1 billion (2024), against an average of $19.5 billion.
- The sharpest annual moves came in 2023 and 2024: Intangibles dropped 7.53% in 2023, then slipped 16.6% in 2024.
- Viatris' Intangibles stood at $22.6 billion in 2022, then decreased by 15.15% to $19.2 billion in 2023, then retreated by 11.0% to $17.1 billion in 2024, then declined by 11.53% to $15.1 billion in 2025, then retreated by 4.1% to $14.5 billion in 2026.
- Business Quant data shows VTRS's Intangibles at $14.5 billion in Q1 2026, $15.1 billion in Q4 2025, and $15.7 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 3.45 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 918.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 21.28 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 13.68 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 2.23 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 3.20 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 1.12 Bn |
| 10 | Alkermes | 8.02 Bn | 7.37 Bn | 397.90 Mn | 1.80 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 13.68 Bn |
| Mar 31, 2026 | 14.48 Bn |
| Dec 31, 2025 | 15.10 Bn |
| Sep 30, 2025 | 15.72 Bn |
| Jun 30, 2025 | 16.32 Bn |
| Mar 31, 2025 | 16.66 Bn |
| Dec 31, 2024 | 17.07 Bn |
| Sep 30, 2024 | 17.98 Bn |
| Jun 30, 2024 | 18.42 Bn |
| Mar 31, 2024 | 19.13 Bn |
| Dec 31, 2023 | 19.18 Bn |
| Sep 30, 2023 | 21.28 Bn |
| Jun 30, 2023 | 22.08 Bn |
| Mar 31, 2023 | 22.70 Bn |
| Dec 31, 2022 | 22.61 Bn |
| Sep 30, 2022 | 23.01 Bn |
| Jun 30, 2022 | 24.10 Bn |
| Mar 31, 2022 | 25.25 Bn |
| Dec 31, 2021 | 26.13 Bn |
| Sep 30, 2021 | 26.99 Bn |